Salivary Alpha Amylase as a Biomarker of Transdermal Vagus Nerve Stimulation

Completed · Not applicable · Has a placebo group

Conditions studied: No Condition Salivary Alpha Amylase

In brief

The proposed project tests the hypothesis that salivary alpha amylase concentration is a reliable biomarker of the effect of transdermal vagus nerve stimulation (tVNS) in humans.

Key facts

Study ID

NCT03854539

Run by

Arkansas Tech University

People needed

100

Starts

2018-03-31

Expected to finish

2020-06-08

Last updated by the study team

2020-06-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy individuals

You may not qualify if…

• NA

Where it is running

• Arkansas Tech University — Russellville, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.